Hypotensive Agents Reduce Bleeding in ESS - Summary - MDSpire

Hypotensive Agents Reduce Bleeding in ESS

Diltiazem, esmolol, dexmedetomidine, labetalol, and clonidine were associated with improved surgical field quality and comparable safety profiles

  • By

  • Olivia Anderson

  • January 30, 2026

  • 3 min

Share

Objective:

To evaluate the effectiveness and safety of pharmacologic agents for inducing controlled hypotension to reduce intraoperative bleeding during endoscopic sinus surgery (ESS).

Key Findings:
  • text
Interpretation:

Controlled hypotension during ESS can be effectively achieved with various pharmacologic agents, allowing for tailored drug selection based on patient and procedural needs.

Limitations:
  • text
Conclusion:

Future research should focus on standardizing protocols and emphasizing individualized treatment strategies for controlled hypotension in ESS.

Original Source(s)

Hypotensive Agents Reduce Bleeding in ESS

  • by Olivia Anderson

  • January 30, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Opioid Prescribing Trends After Guidelines

Large US data set tracks postoperative analgesic use over a decade.

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.